Abstract

Budesonide 1-mg//10-mL Mucolox Oral Suspensions

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2018 - Volume 22, Number 4

Page(s): 317

Download in electronic PDF format for $75
  • Budesonide 1-mg//10-mL Mucolox Oral Suspensions Page 1

Abstract

A formulation for preparing Budesonide 1-mg//10-mL Mucolox Oral Suspensions. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • budesonide
  • anti-inflammatory agent
  • inflammation
  • corticosteroid
  • steroid preparation
  • mucosal delivery system

Related Categories

  • FORMULATIONS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2018
Pg. 317
Budesonide 1-mg//10-mL Mucolox Oral Suspensions
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2017
Pg. 322-329
Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox)
Author(s): Ip Kendice, Carvalho Maria, Shan Ashley, Banov Daniel
Mar/Apr 2004
Pg. 101-105
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 254-261
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Author(s): Klemmer Anja, Krämer Irene, Kamin Wolfgang
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Jul/Aug 2014
Pg. 287-290
Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis
Author(s): Reisacher William, Rudner Shara, Kotik Viktoriya
Jul/Aug 2012
Pg. 288-293
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide
Author(s): Zur Eyal
Sep/Oct 2021
Pg. 416
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 155-158
Utilization of Compounded Medications in an Oral Medicine Practice
Author(s): Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Jul/Aug 2021
Pg. 323
Budesonide 0.0.25% Mucoadhesive Gel
Author(s): Allen Loyd V Jr
Nov/Dec 1999
Pg. 496-500
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Author(s): Goodwin Donald A, Fuhram L Clifton
Jan/Feb 2007
Pg. 72
Dexamethasone 1-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jan/Feb 2007
Pg. 77
Prednisone 10-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jan/Feb 2007
Pg. 78
Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 2023
Pg. 340-346
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Author(s): Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Jan/Feb 2018
Pg. 66-75
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension
Author(s): Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
Nov/Dec 2016
Pg. 495-500
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 242
Celecoxib 10-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr